Table 2 Clinical efficacy data at final analysis on 43 patients
Number of cycles (median - range) | 5 [1 - 21] |
Treatment response (n - %) | |
CR | 1/43 – 2.3% |
PR | 7/43 - 16.3% |
SD | 17/43 - 39.5% |
PD | 18/43 - 41.9% |
Clinical benefit | 25/43 - 58.1% |
ORR | 8/43 - 18.6% |
TTP (median - range) | 5 [2 - 21] months |
OS (median - range) | 9 [3 - 29] months |
Percentage of alive patients (n - %) | |
year 1 | 16/43 - 37.2% |
year 2 | 4/43 - 9.3% |